alpha-Amylcinnamyl isovalerate
Common Name: |
alpha-Amylcinnamyl isovalerate |
IUPAC Name: |
[(2Z)-2-benzylideneheptyl] 3-methylbutanoate |
Molecular Formula: |
C19H28O2 |
SMILES: |
CCCCCC(=CC1=CC=CC=C1)COC(=O)CC(C)C |
Inchi: |
1S/C19H28O2/c1-4-5-7-12-18(14-17-10-8-6-9-11-17)15-21-19(20)13-16(2)3/h6,8-11,14,16H,4-5,7,12-13,15H2,1-3H3/b18-14- |
Inchi Key: |
RNKTVAMGERKTEZ-JXAWBTAJSA-N |
Cas No: |
7493-80-3 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
288.42 |
Mass (g/mol) |
288.209 |
Molar Refractivity |
90.70 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
10 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
21 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
392.00 to 393.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.53 |
LogP |
5.238 |
iLOGP |
4.16 |
XLOGP3 |
6.20 |
WLOGP |
5.13 |
MLOGP |
4.53 |
ESOL Log S |
-5.09 |
ESOL Solubility (mg/ml) |
0.002 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-6.54 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-5.81 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.66 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.106 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.484 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |